A Microdose Evaluation Study of ABY-029 in Head and Neck Oncology Surgery

Condition:   Head and Neck Cancer
Intervention:   Drug: ABY-029
Sponsors:   Dartmouth-Hitchcock Medical Center;   Dartmouth College
Not yet recruiting - verified September 2017

http://ift.tt/2xzI5ta